Research groups
Matthias Friedrich
Postdoctoral Researcher (Oxford-Janssen)
I am passionate about translating research findings into clinical benefit for patients with immune-mediated inflammatory diseases (IMIDs). Within the Oxford-Janssen Cartography project (lead: Prof. Uhlig) and as part of Chris Buckley's research group, I focus on dissecting pathogenic molecular and cellular networks in rheumatoid arthritis and psoriatic arthritis. Through applying cross-disease multi-omic patient cohort profiling, molecular and cellular biology, and bioinformatic analyses, this will allow us to identify potential therapeutic targets to develop improved medicines.
Recent publications
-
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10.
Journal article
Richter FC. et al, (2023), Embo j
-
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responses
Preprint
Heuberger CE. et al, (2023)
-
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Journal article
Woelfel S. et al, (2022), Aliment pharmacol ther
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.
Journal article
Cavounidis A. et al, (2022), Mucosal immunol
-
BMP pathway antagonism by Grem1 regulates epithelial cell fate in intestinal regeneration
Journal article
LEEDHAM S. et al, (2021), Gastroenterology